Elevating precision medicine to the forefront of every cancer treatment journey. At Elevation Oncology, we make drugs that make genomic tests actionable.
Location: United States, New York
Total raised: $147.5M
Founded date: 2019
Investors 4
| Date | Name | Website |
| 24.07.2020 | Aisling Ca... | aislingcap... |
| - | K2 HealthV... | k2healthve... |
| - | Timefolio ... | timefolioc... |
| - | K2 HealthV... | k2hv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.07.2022 | - | $50M | - |
| 20.11.2020 | Series B | $65M | - |
| 22.07.2020 | Series A | $32.5M | - |
Mentions in press and media 27
| Date | Title | Description | Source |
| 23.08.2023 | FORE Biotherapeutics raised a $75M Series D and announced an... | Update: Details about funding and employee count from a FORE spokesperson have been added. (8/23/23,... | technical.... |
| 08.06.2023 | Finance: Elevation Oncology Announces Pricing of $50M IPO | What You Should Know: Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focuse... | hitconsult... |
| 28.07.2022 | Elevation Oncology Secures $50M Loan Facility with K2 Health... | What You Should Know: Elevation Oncology, a clinical-stage biopharmaceutical company focused on the ... | hitconsult... |
| 10.01.2022 | Elevation Oncology Highlights 2021 Achievements and Outlines... | NEW YORK, Jan. 10, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | marketscre... |
| 12.11.2021 | Elevation Oncology Reports Third Quarter 2021 Financial Resu... | NEW YORK, Nov. 12, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | salamancap... |
| 20.10.2021 | Elevation Oncology : Announces the Promotion of Valerie Maly... | NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | marketscre... |
| 12.08.2021 | Elevation Oncology Reports Second Quarter 2021 Financial Res... | prnewswire... | |
| 12.08.2021 | Elevation Oncology Reports Second Quarter 2021 Financial Res... | NEW YORK, Aug. 12, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | salamancap... |
| 25.06.2021 | Elevation Oncology : Announces Pricing of Initial Public Off... | NEW YORK, June 24, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | marketscre... |
| 24.06.2021 | Elevation Oncology Announces Pricing of Initial Public Offer... | prnewswire... |
Show more